Cardiovascular Subspecialties Shine in Alayaran.com's Most-Read Stories of January 2025

The first month of the year has reinforced what healthcare experts already known: cardiovascular research and practice encompass a wide range of interests among TCTMD readers, as revealed in our most-popular stories of January 2025.

A closer look at these top stories reveals a diverse range of topics, including temporary halts to US pulsed-field ablation cases (Johnson & Johnson Halts Varipulse Cases in the US), cardiac arrest and sugar-sweetened beverages, heart failure and interventional cardiology. Other significant subjects covered include cardiometabolic disease, cardiovascular surgery, kidney disease, private equity ownership of hospitals, and more.

Our top article this January examined a critical issue: researchers temporarily paused pulsed-field ablation cases in the US to investigate four neurovascular events seen in external evaluation studies (J&J Halts Varipulse Pulsed-Field Ablation Cases in the US).

A groundbreaking global study highlighted the alarming increase in diabetes and cardiovascular disease linked to sugar-sweetened beverages, even in sub-Saharan Africa where Western diets are less prevalent (Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates).

In addition, our review of GLP-1 drugs found that these meds may be effective for weight management, helping combat the global obesity epidemic (Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review).

Meanwhile, several leading surgical societies have taken a stance on private equity ownership of hospitals, citing concerns over patient experience and treatment quality.

Recent studies have shed new light on various topics in cardiovascular medicine, including the link between osteoporosis injections and increased mortality rates in dialysis patients (Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients).